Literature DB >> 20063523

Thyroid carcinoma in the United Arab Emirates: perspectives and experience of a tertiary care hospital.

Nabil Al-Zaher1, Suhail Al-Salam, Hassan El Teraifi.   

Abstract

BACKGROUND: Although the distribution of thyroid carcinoma in the Arab Gulf States has been described, no previous study has examined the characteristic clinicopathologic features of thyroid carcinoma cases in the United Arab Emirates.
METHODS: The medical records of 135 patients with thyroid carcinoma diagnosed over a 15-year period (1991-2005) at Tawam Hospital, the national referral oncology center in the UAE, were retrospectively studied and the cases classified according to the histologic classification of the World Health Organization (WHO).
RESULTS: Seventy-eight patients (58%) were diagnosed before the age of 45 years with an overall peak incidence in the fourth and fifth decades. The female to male ratio was 2.4:1. Eighty-four percent had papillary thyroid carcinoma (PTC), while follicular thyroid carcinoma (FTC), anaplastic thyroid carcinoma and medullary carcinoma comprised 14%, 1.4% and 0.6%, respectively. The conventional classical variant of papillary carcinoma was the most common type. Three-quarters of the papillary carcinomas presented as multinodular goiter, while one-fifth presented as a solitary thyroid nodule. Minimal invasive follicular carcinoma was the most common variant of follicular carcinoma.
CONCLUSION: Thyroid carcinoma in the United Arab Emirates seems to be more common among females and female gender may be a risk factor. Age < 45 years can be considered an important prognostic factor as well as a possible risk factor. PTC predominates the histologic pattern of thyroid carcinoma, which is usually associated with an iodide-sufficient area.

Entities:  

Mesh:

Year:  2008        PMID: 20063523     DOI: 10.1016/s1658-3876(08)50055-0

Source DB:  PubMed          Journal:  Hematol Oncol Stem Cell Ther


  13 in total

1.  The rising trend in papillary thyroid carcinoma. True increase or over diagnosis?

Authors:  Manar H Hajeer; Heyam A Awad; Niveen I Abdullah; Ghadeer H Almuhaisen; Loay E Abudalu
Journal:  Saudi Med J       Date:  2018-02       Impact factor: 1.484

2.  Thyroid malignancy among patients with thyroid nodules in the United Arab Emirates: a five-year retrospective tertiary Centre analysis.

Authors:  Eiman Alseddeeqi; Raqwana Baharoon; Rawia Mohamed; Jenan Ghaith; Abeer Al-Helali; Luai A Ahmed
Journal:  Thyroid Res       Date:  2018-11-30

3.  BRAF and KRAS mutations in papillary thyroid carcinoma in the United Arab Emirates.

Authors:  Suhail Al-Salam; Charu Sharma; Bachar Afandi; Khaled Al Dahmani; Ali S Al-Zahrani; Amal Al Shamsi; Juma Al Kaabi
Journal:  PLoS One       Date:  2020-04-21       Impact factor: 3.240

4.  Decline in radioiodine use but not total thyroidectomy in thyroid cancer patients treated in the United Arab Emirates - A retrospective study.

Authors:  Malik Azhar; Faisal Aziz; Salama Almuhairi; Mohammad Alfelasi; Ali Elhouni; Rizwan Syed; Humaid O Al-Shamsi; Khaled M Aldahmani
Journal:  Ann Med Surg (Lond)       Date:  2021-03-04

5.  Is there adenoma-carcinoma sequence between benign adenoma and papillary cancer of thyroid: A genomic linkage study.

Authors:  Ramesh Bangaraiahgari; Ramakanth Bhargav Panchangam; Pradeep Puthenveetil; Sabaretnam Mayilvaganan; Rajesh Bangaraiahgari; Rajkiran Reddy Banala; Poongkodi Karunakaran; Rafi Md
Journal:  Ann Med Surg (Lond)       Date:  2020-12-02

6.  Spectrum and Prevalence of Thyroid Diseases at a Tertiary Referral Hospital in Mogadishu, Somalia: A Retrospective Study of 976 Cases.

Authors:  Mohamed A Hassan-Kadle; Abdulkamil Abdullahi Adani; Hasan Huseyin Eker; Esra Keles; Marian Muse Osman; Hussein Mahdi Ahmed; Şeyma Görçin Karaketir
Journal:  Int J Endocrinol       Date:  2021-12-26       Impact factor: 3.257

7.  Male Sex Is an Independent Predictor of Recurrence-Free Survival in Middle Eastern Papillary Thyroid Carcinoma.

Authors:  Abdul K Siraj; Sandeep Kumar Parvathareddy; Padmanaban Annaiyappanaidu; Nabil Siraj; Saif S Al-Sobhi; Fouad Al-Dayel; Khawla S Al-Kuraya
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-10       Impact factor: 5.555

8.  The Pattern of Thyroid Malignancy and Its Associated Characteristics Among United Arab Emirates Population With More Focus on Patients in the Bethesda III Category.

Authors:  Mahmoud A Kiblawi; Kashif Hafeez; Shahed K Lami; Omar A Al Teneiji; Abdullah N Al Mubarak; Thaer K Swaid; Sundos A Ahmed; Roaa S Alabiri; Ruba S Alabiri
Journal:  Cureus       Date:  2022-03-19

9.  Lymph node ratio is superior to AJCC N stage for predicting recurrence in papillary thyroid carcinoma.

Authors:  Sandeep Kumar Parvathareddy; Abdul K Siraj; Zeeshan Qadri; Saeeda O Ahmed; Felisa DeVera; Saif Al-Sobhi; Fouad Al-Dayel; Khawla S Al-Kuraya
Journal:  Endocr Connect       Date:  2022-02-16       Impact factor: 3.335

10.  APOBEC SBS13 Mutational Signature-A Novel Predictor of Radioactive Iodine Refractory Papillary Thyroid Carcinoma.

Authors:  Sarah Siraj; Tariq Masoodi; Abdul K Siraj; Saud Azam; Zeeshan Qadri; Sandeep K Parvathareddy; Rong Bu; Khawar S Siddiqui; Saif S Al-Sobhi; Mohammed AlDawish; Khawla S Al-Kuraya
Journal:  Cancers (Basel)       Date:  2022-03-21       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.